
@PEACH_Study1i
iAccount based inSpain
About this account
- Account based in
- Spain
- Connected via
- United Kingdom App Store
Account-level information from X, not a live location or the device used for a specific post.
Procalcitonin: Evaluation of Antibiotic use in COVID-19 Hospitalised patients. @UniversityLeeds and @CTRCardiffUni
Leeds and Cardiff
Joined November 2020
- Tweets84
- Following34
- Followers108
- Likes85
Pinned Tweet
Latest publication from @PEACH_Study1
Cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study | Journal of Antimicrobial Chemotherapy | Oxford Academic academic.oup.com/jac/advance…
PEACH retweeted
Delighted that the final study synopsis for @PEACH_Study1 has now been published in @NIHRresearch library! Full report and results in the 'related links' here: cardiff.ac.uk/centre-for-tri…
@CTRCardiffUni @CarrolEnitan @j_sandoe @UniversityLeeds
💥💥💥MAIN RESULTS💥💥💥
The PEACH team are delighted to finally share the main results of this study!
@CarrolEnitan @j_sandoe @emma_tj1 @Dr_JoanneEuden @LBrookesHowell @DetelinaGrozeva @CTRCardiffUni @UniversityLeeds and many others.
academic.oup.com/jac/advance…
Great to share our work on @PEACH_Study1 on #procalcitonin shortening antibiotic course length during #Covid #ECCMID2024 or #ESCMIDGlobal
Replying to @PEACH_Study1
@PEACH_Study1 is an excellent example of using diagnostics to reduce inappropriate antibiotics use during a viral pandemic outbreak @glgamr #eccmid2024 #escmidglobal
Last day of (usual) work before I head to Barcelona tomorrow for @ESCMID. Looking forward to seeing some colleagues and presenting the results of @PEACH_Study1 with @emma_tj1.
And we are here @ESCMID about to go to a sepsis talk by Mervyn Singer and then present the results of our @PEACH_Study1.
💥RESULTS 💥
We are delighted to finally share the results of our PEACH study.
Did procalcitonin tests affect antibiotic prescribing for early COVID-19... youtu.be/iLAjfJ562cc?feature… via @YouTube
@NIHRresearch @j_sandoe @CarrolEnitan @CTRCardiffUni @UniversityLeeds #AMS #AMR
We’re looking forward to presenting results of the @PEACH_Study1 at @ECCMID in Barcelona next month. Thank you to everyone who was involved.
@j_sandoe @CarrolEnitan @emma_tj1 @Dr_JoanneEuden @DetelinaGrozeva @WMaboshe @LBrookesHowell Josie Henley, Phil Pallmann & many more!
First published findings from @PEACH_Study1 qualitative work stream today in @BMJ_Open.
bmjopen.bmj.com/content/13/1…
@josie_henley @LBrookesHowell @Dr_JoanneEuden @j_sandoe @emma_tj1 @CarrolEnitan @CTRCardiffUni @UniversityLeeds @NIHRresearch
PEACH retweeted
It’s the end of #WAAW2023 & we’ve been highlighting work from our infections division at @CTRCardiffUni. #AMR & antimicrobial stewardship needs to be at forefront of our minds. We need better diagnostics, implemented quickly once evidence exists for better patient outcomes.
PEACH retweeted
Tackling AMR Together 🤝💊
Collaboration is key in fighting AMR. Discover the united efforts in our #WAAW2023 blog.
🔗blogs.cardiff.ac.uk/centre-f…
@ResearchWales @CUBLSResearch @UKCTUNetwork @TreialonCymru @kerryhood @DPMRes @Pronto_Trial @PEACH_Study1 @BATCH_trial @CarrolEnitan
We have just about finished analysis for @PEACH_Study1 (Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients). Make sure you follow for updates, results and dissemination activities. #WAAW2023
@CarrolEnitan @j_sandoe @NIHRresearch @UniversityLeeds
As well as our @PEACH_Study1, see what other studies @CTRCardiffUni are conducting on diagnosis of infections.
Antimicrobial resistance is an urgent global threat. It is vital that we #KeepAntibioticsWorking
@j_sandoe @CarrolEnitan
🌍💊This #WAAW2023, learn how @CTRCardiffUni is contributing to research on antimicrobial resistance (AMR).
Our World Antimicrobial Resistance Awareness Week blog:
🔗blogs.cardiff.ac.uk/centre-f…
@ResearchWales @UKCTUNetwork @Pronto_Trial @PEACH_Study1 @BATCH_trial @CarrolEnitan
Alot of work ongoing in the background to get manuscripts submitted. We have an incredibly rich repository of clinical data which reflects the huge effort from all our participating Trusts. We look forward to sharing the results of this study with you over the next few months.
We have finished all analysis. We hope to have main results of @PEACH_Study1 published very soon alongside our qualitative and health economics papers.
cardiff.ac.uk/centre-for-tri…
@j_sandoe @CarrolEnitan @AntibioticLeeds @MartinLlewelyn @LBrookesHowell @emma_tj1 @Dr_JoanneEuden
Thank you to all our sites for participating in the close down process. All sites are now closed.
Analysis of data is almost complete and we look forward to sharing the results in due course.
Looking forward to presenting the results of our study at an internal @CTRCardiffUni meeting this week with @CarrolEnitan, and with our wider investigator group next month. Thank you again to all site staff who worked so hard to gather patient data for this study. #ICTD2023
PEACH retweeted
Tomorrow is #ICTD2023 and a great way to roll into next week when we discuss results of @PEACH_Study1, @BATCH_trial, @PRECISE_study and finalise plans for our first PROTECT stakeholder meeting in Leeds with @CarrolEnitan and @CTRCardiffUni colleagues.
Thank you to our sites for your cooperation during the close down process. Half have officially been closed. We are continuing to analyse our main work package and will publish our results within the next couple of months.
PEACH retweeted
“It was admirable that the team were committed to such early involvement.” - Margaret, co-applicant
Learn more about how the @PEACH_Study1 involved public contributors and how those involved found the experience: nihr.ac.uk/documents/case-st…












